Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huanggang Yinhe Aarti Pharmaceutical is a China-based Sino-foreign joint venture pharmaceutical manufacturer focused on active pharmaceutical ingredients, pharmaceutical intermediates, and fine chemical products. The company appears to be commercially active and is best known for metronidazole-related products, with additional offerings spanning imidazole intermediates and other chemical raw materials. Its business is oriented toward manufacturing and export rather than novel drug discovery, with products sold into Europe, the Americas, Southeast Asia, India, and other markets. Available sources describe GMP-aligned facilities, quality inspection capabilities, and environmental protection investments. Overall, the company looks like a small-molecule API and intermediates supplier serving global pharmaceutical and chemical customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huanggang Yinhe Aarti Pharmaceutical.